Appropriate for
Recommended for individuals with chronic inflammation, persistent fatigue, heavy-metal or microplastic toxicity, or those preparing for advanced regenerative treatments.
.jpg&w=1920&q=75&dpl=dpl_Ftjrp6gffSpqX7TFmvNAynejKwEf)
Therapeutic apheresis is an extracorporeal medical procedure that enables, through specific technologies, the separation and treatment of certain blood components. At ImageRegenerative Institute in St. Moritz, Toxopheresis® is offered as part of a personalized clinical pathway, in which medical evaluation and diagnostic tests guide the choice of treatment, the definition of objectives and subsequent monitoring. The Image Regenerative approach is based on a fundamental principle: every intervention must respond to a clinical indication and be part of a care program built on the individual characteristics of the person.
Recommended for individuals with chronic inflammation, persistent fatigue, heavy-metal or microplastic toxicity, or those preparing for advanced regenerative treatments.
Suitable for adult patients, generally aged 25 and above, following a personalised medical assessment.
Each session lasts approximately 90 to 120 minutes in a controlled medical environment.
An initial cycle of 2–3 sessions is recommended, spaced 2–4 weeks apart, and adjusted according to clinical response.
Not indicated during pregnancy or in patients with bleeding disorders, a prior medical evaluation is always required.
Select your preferred time and date
Therapeutic apheresis encompasses various procedures that involve temporarily withdrawing blood, treating it through an extracorporeal circuit, and returning the components specified by the protocol. Depending on the technique employed, the objective may be to remove or reduce specific plasma or cellular components involved in certain pathological conditions. There are various apheresis modalities, including plasmapheresis, therapeutic plasma exchange, and selective filtration or adsorption techniques. These procedures are not equivalent: they differ in mechanism of action, substances treated, clinical indications, and safety profile. The choice depends on the diagnosis, therapeutic objectives, patient characteristics, and available evidence.
Toxopheresis® is presented as an extracorporeal blood treatment method based on selective filtration. Its use is evaluated by the physician based on the clinical picture and available examinations, with the objective of identifying an appropriate protocol. The central characteristic of the IMAGE Regenerative approach is not the standardized execution of the procedure, but its integration into a clinical pathway that includes:
The actual capacity to remove specific substances, as well as possible clinical benefits, depends on the technology used and must be evaluated based on the evidence relating to the specific protocol.
The procedure involves the use of an extracorporeal circuit through which blood is temporarily withdrawn and treated using the system specified by the medical protocol. The method of separation, filtration, and return of blood components depends on the technology employed. Before treatment, the physician evaluates the patient's general condition, available vascular access, and the clinical parameters necessary to proceed. During the session, healthcare personnel monitor the patient and check relevant parameters. At the end, the expected verifications are performed and instructions for the subsequent period are provided. The procedure requires qualified personnel, appropriate equipment, and a clinical environment suitable for managing any complications.
Therapeutic apheresis is used in various medical specialties, including hematology, neurology, nephrology, and immunology, for specific conditions where recognized indications exist. Indications vary significantly depending on the technique. In the context of personalized medicine and longevity programs, interest in extracorporeal filtration technologies also concerns the study of certain biomarkers and circulating components. However, it is essential to distinguish established therapeutic applications from uses still under research.
Currently, it is not possible to consider apheresis, in general, a proven treatment to prevent aging, increase longevity, improve cognitive performance, or indiscriminately treat conditions of fatigue and chronic inflammation. The use for removal of microplastics or specific environmental contaminants also requires clinical and analytical evidence related to the method used. At IMAGE Regenerative, the specialist evaluation serves precisely to clarify whether appropriate clinical grounds exist to consider the treatment.
Longevity medicine focuses on promoting health over time through prevention, identification of risk factors, and interventions based on individual characteristics. This approach requires in-depth knowledge of the person, which may include the study of metabolic, cardiovascular, and inflammatory parameters, lifestyle, and any existing clinical conditions. Extracorporeal technologies represent a specialized area of medicine, not a universal prevention procedure. Their potential integration into a longevity pathway must therefore be evaluated separately from established preventive strategies.
Longevity is not built through a single treatment, but through appropriate clinical decisions, prevention, and continuity of care.
The first consultation is dedicated to collecting medical history, evaluating health status, any pathologies, ongoing therapies, and the patient's objectives.
The physician verifies whether there are elements that justify further investigation or consideration of an extracorporeal procedure.
When appropriate, laboratory tests are requested to deepen the clinical picture, verify suitability for treatment, and define any reference parameters.
The tests are selected according to the individual situation and do not constitute a standard panel identical for everyone.
Based on the assessment, the physician determines whether the procedure is indicated, what objectives are reasonably achievable, and what precautions to adopt.
Operational modalities, possible benefits, limitations, alternatives, and risks are explained.
The treatment is performed with dedicated healthcare assistance and monitoring of clinical parameters.
The patient can communicate any symptoms or discomfort to the attending personnel at any time.
After the session, when necessary, clinical re-evaluations and any laboratory verifications are scheduled.
Follow-up allows documenting observed effects, evaluating tolerability, and establishing whether further interventions are necessary.
Preparation for a Toxopheresis® session is an integral part of the care pathway and is defined by the medical team of IMAGE Regenerative Institute according to clinical conditions and the planned protocol. Before treatment, it is important to share with the specialist all relevant information about one's health status, including any pathologies, allergies, ongoing drug therapies, or previous reactions to extracorporeal procedures.
At the appointment, it is advisable to bring the most recent clinical tests and an updated list of medications taken, so as to allow the physician to complete the necessary verifications and provide personalized instructions. Any modifications to usual therapies must always be agreed with the specialist, without autonomously discontinuing any medication.
A Toxopheresis® session at IMAGE Regenerative Institute in St. Moritz has an indicative duration of 2-4 hours, which may vary depending on the medical protocol, individual characteristics, and the blood flow tolerated during the procedure. The treatment takes place in a dedicated clinical environment, with constant assistance from qualified healthcare personnel and monitoring of relevant parameters.
When scheduling the appointment, the team provides all necessary information about expected times and procedures, allowing the patient to face the session with a clear understanding of the different phases of treatment.
The number of Toxopheresis® sessions is established individually, based on the initial clinical assessment, therapeutic objectives, and patient characteristics. There is no universal protocol applicable to all people, as the frequency and possible repetition of treatment depend on the medical indication and subsequent re-evaluations.
The pathway involves continuous dialogue between physician and patient, through which the tolerability of the procedure, clinical parameters of interest, and any observed results are monitored. This approach allows defining, when indicated, the need for further sessions, maintaining the treatment within a personalized medical program.
Safety represents a central element in the IMAGE Regenerative Institute approach. Like any extracorporeal medical procedure, Toxopheresis® also requires careful preventive assessment of patient suitability, during which cardiovascular conditions, hematological parameters, coagulation, ongoing drug therapies, and availability of adequate vascular access are considered.
Although the treatment is performed in a controlled clinical environment, adverse effects may occur such as reduced blood pressure, nausea, weakness, electrolyte alterations, reactions related to anticoagulation, or problems associated with vascular access. Allergic reactions are also possible and, in certain circumstances, more significant complications, whose nature and frequency also depend on the technology used and individual conditions.
For this reason, before proceeding, the physician carefully evaluates the relationship between potential benefits, risks, and available alternatives, sharing with the patient the information necessary for an informed decision. Toxopheresis® is not indicated for everyone: the appropriateness of treatment is established exclusively on the basis of an individual medical assessment.
At IMAGE Regenerative Institute, health is interpreted as the result of a complex balance between biological conditions, individual characteristics, and lifestyle. For this reason, the patient's pathway does not end with a single procedure, but is part of a broader vision of personalized medicine, prevention, and longevity.
When clinically appropriate, Toxopheresis® may be considered as part of a program that includes diagnostic investigations, monitoring of risk factors, and targeted interventions on nutrition, physical activity, sleep quality, and stress management. The possibility of integrating additional treatments is considered by the medical team according to individual needs, specific indications, and available scientific evidence.
It is precisely this integration between knowledge of biological processes, clinical expertise, and practical application of medicine that characterizes the IMAGE philosophy: not to propose isolated treatments, but to build care pathways in which each intervention has a precise purpose and is accompanied by an evaluation of results.
The objective is to guide the person toward greater awareness of their health, through a continuous relationship with the physician and a program capable of evolving over time, according to clinical needs and individual objectives.
Select your preferred time and date
Apheresis filters plasma to remove toxins, heavy metals and immune complexes; Toxopheresis® is an advanced form enhanced to also target microplastics, infectious agents and inflammatory mediators.
It is designed for adults experiencing chronic inflammation, heavy-metal or microplastic toxicity, autoimmune conditions, long COVID, or who are preparing for advanced regenerative therapies.
Each session lasts about 90-120 minutes. Typically 2–3 sessions spaced 2–4 weeks apart are recommended, though the exact plan is tailored individually
Yes, the procedure is conducted in a medical environment with high-quality filtration membranes and minimal anticoagulant use. Side-effects are rare; a medical evaluation is required before treatment.
Absolutely. It is designed to complement IV therapies (e.g., NAD+), bio-resonance, bio-energetic massage and other regenerative protocols to maximise overall outcomes.
If you need more information, call us at +39 02 76280736, message us on WhatsApp, email us at info.milano@imageregenerative.com, or use the form below.